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The aim of this study was to evaluate how a fish bone hydrolysate (FBH) from blue whiting 
(Micromesistius poutassou) fish bones may improve muscle astaxanthin (Ax) deposition in 
Atlantic salmon (Salmo salar). Fish (1.7 kg) were reared in 12 net-pens and fed with one of 
four practical formulated diets for 78 days. All diets (D) were balanced to meet dietary 
phosphorus (P) requirement (8 g kg
-1
 P): the control diet (D1) and diet D4 were added CaPO4 
as P source, diets D2 and D3 were added P from a spray dried FBH ingredient at 2.1 and 4.2 
%, respectively, and D2 was further balanced with CaPO4. Diet D4 was added K2SO4 to study 
potential impacts of sulfate in H2SO4 used for mineral hydrolysis. An in vitro cell culture trial 
with hepatocytes (600 g salmon) was performed to study the effects of FBH on Ax uptake and 
transport. The soluble fish bone compounds significantly increased specific muscle Ax 
retention (mg kg
-1
 weight gain) by 35 % (P < 0.05) in fish fed D3, possibly explained by 
improved Ax digestibility (ns) followed by increased circulating Ax and a tendency towards 
increased tissue Ax deposition (ns). Reduced metabolic turnover of Ax was indicated, with 
about 10 % more of absorbed Ax retained in muscle of fish fed D3. The in vitro trial showed 
no direct impact of FBH on hepatic Ax uptake. However, the FBH ingredient altered the 
muscle connective tissue by stimulating the production of proteoglycans and their sulfated 
glycosaminoglycans (GAGs) significantly. This study suggests that hydrolysed compounds 
from fish bones may improve Ax utilization in salmon, and that they may have an impact on 
the functional properties of the muscle. 





















The market value of Atlantic salmon (Salmo salar) products is closely related to the pink 
flesh pigmentation (Steine et al., 2005; Alfnes et al., 2006). Normal or above normal fillet 
redness is therefore essential for consumer acceptance. However, it is occasionally difficult to 
acquire satisfying fillet pigmentation, which is set by the industry to 6-7 mg carotenoid kg
-1
. 
In salmonids, digestive and absorptive processes, and metabolic turnover of Ax, influence 
utilization and flesh deposition of carotenoids (Torrissen et al., 1989; Bjerkeng et al., 1992; 
Bjerkeng 2008; Ytrestøyl et al., 2004, 2005, 2006). Usually, less than 10 % of ingested Ax is 
efficiently retained in the flesh of Atlantic salmon (Torrissen et al., 1989; Wathne et al., 
1998). A low Ax deposition rate in the flesh may be a result of low intestinal Ax uptake or 
high metabolic turnover of digested Ax. The carotenoid retention vary considerably during 
the seawater production phase (Torrissen et al., 1995; Mørkøre and Rørvik 2001; Nordgården 
et al., 2003; Ytrestøyl et al., 2008) and there are indications of a higher Ax turnover during 
periods with increased oxidative stress (Nordgården et al., 2003). In addition, Ax may also be 
used as a powerful antioxidant in biological reaction systems (Camera et al., 2008; Goswami 
et al., 2010) and as a precursor of vitamin A in salmonid fishes (Schiedt et al., 1985; Guillou 
et al., 1989).  
In Atlantic salmon, phosphorus (P) in fish bone hydrolysate (FBH) produced by acid 
hydrolysis of blue whiting (Micromesistius poutassou) and Atlantic herring (Clupea 
harengus) fish bones, was highly available and covered the P requirement for growth, 
mineralization and skeletal development (Albrektsen et al., 2013, 2017; Ytteborg et al., 2016). 
The fish bone ingredients also improved nutrient digestibility (Albrektsen et al., 2013) and 
significantly increased plasma, liver and whole body Ax concentration in A. salmon postsmolt 


















(Albrektsen et al., 2017), possibly explaining the increased growth. As dietary Ax is lipid-
soluble and absorbed and transported by the same mechanisms as dietary lipids, the improved 
pigmentation may be explained by improved lipid digestion. The fish bone ingredients 
contain a range of macro and micro-minerals, bone proteins/collagens, amino acids, non-
protein N compounds, glycoproteins and other soluble compounds, and it is possible that 
some of these compounds may be involved in the regulation of Ax uptake, transport and 
metabolism. The amino acid profile of the fish bone ingredients from blue whiting confirms 
presence of bone collagen proteins with characteristic high levels of Hydroxyproline (Hyp), 
Proline (Pro) and Glycine (Gly) (Toppe et al., 2007). Some of these non-essential amino acids 
has improved growth (Aksnes et al., 2008) and/or muscle quality (Albrektsen et al., 2010; 
Larsson et al., 2014; Østbye et al., 2017a) in Atlantic salmon. A changed composition of the 
connective tissue compounds in skeletal muscle may be of importance for the textural 
properties and quality of the flesh (Moreno et al., 2012; Tingbo et al., 2005; Torgersen et al., 
2013).  
In vitro studies have shown positive impacts of fish bone ingredients on hepatocytes by down-
regulation of genes involved in stress and inflammation, and up-regulation of genes involved 
in the energy metabolism, suggesting potential health effects (Østbye et al., 2017b). In this 
study we wanted to investigate if the soluble compounds in the fish bone ingredients could 
affect factors regulating energy metabolism, since this process is also closely connected to the 
formation of reactive oxygen species and inflammatory stress responses. We have previously 
shown that increased oxidative stress in salmon can induce apoptosis, reduce ß-oxidation, 
damage the mitochondria membrane and change the muscle structure (Kjær et al., 2008; 


















The main aim of the present study was to evaluate possible impacts of fish bone ingredients 
on pigment utilization in large, close to slaughter size salmon. This was evaluated by 
measuring dietary impacts on growth, feed intake, feed conversion, Ax digestibility, Ax 
retention, and specific Ax contents in muscle, liver and plasma in salmon. Dietary impacts of 
the fish bone ingredients on connective tissue composition in skeletal muscle, a parameter 
known to influence fish fillet quality, was analysed by FT-IR spectroscopy. An in vitro study 
with hepatocytes from salmon was performed to study effects of the fish bone ingredients on 
genetic markers for uptake and transport of Ax at the cellular level, to reveal the mechanism 
of improved Ax utilization. Genetic markers of health and inflammation was included both in 



















2 Materials and methods 
2.1 Fish bone hydrolysate (FBH) production  
A fish bone meal was separated from a commercial produced blue whiting fish meal 
(Karmsund Fishmeal, AS, Avaldsnes, Norway) by sieving (4.6 mm). The sifted fish bone 
meal contained 41.5 % ash and was mixed with water (1:5 w/w) in 100 L plastic barrels, 
added 95 % H2SO4 (5 % w/w) and hydrolysed (18h) at room temperature (18-20°C) to 
solubilize the minerals from hydroxyapatite. The soluble fraction was manually separated 
from the solids by sieving over a fine mesh cloth (70 µm). The solid phase was washed twice 
with cold water to collect all soluble compounds. The liquid phase was adjusted to pH = 2.1 
with NH3 –solution (25 % w/w) by titration, and to a final pH = 2.8 with KOH (33 % w/w), 
and then stored overnight to precipitate solid material. Floating lipids were manually 
removed, and the clear liquid was pumped into a 100 L steel kettle, and sterilized by heating 
to 90 °C for 5 min. The solid material contained some liquid that was collected by ultra-
centrifugation (10.000 rpm, 10 min) prior to sterilization. The liquid was concentrated by 
evaporation (33 °Brix) and spray dried (Niro Atomizer, Denmark) into a powder (20 – 60 
µm). About 20 kg FBH was produced. The P content in FBH was 9.6 % total P and 9.5 % 
soluble P, which make it suitable as alternative P source (Albrektsen et al., 2017). The 
chemical composition is presented in Results (3.1).  
2.2 Experimental diets 
Four experimental diets were produced at Nofima’s Aquafeed Technology Centre, Bergen, 
Norway. The FBH ingredient was added as an alternative P source at two dietary levels, 
equivalent to 2 and 4 g P kg
-1
 diet. All experimental diets were balanced to meet the 
requirement of available P (8 g kg
-1


















pigment enhancing effects of the ingredient that we expect is not explained by dietary P. The 
basal diet (D1) contained 4 g kg
-1
 soluble P, and was added 4 g kg
-1
 P from either CaPO4 (D1, 
D4) or from FBH (D2, D3). In D2, FBH provided 2 g kg
-1
 P and was added another 2 g kg
-1
 P 
from CaPO4. Diet D4 was supplemented with K2SO4 to evaluate possible impacts of 
potassium (K) in KOH used to adjust pH and SO4 in sulfuric acid used for acid hydrolysis. 
The feed formulation reflected composition of a commercial diet for Atlantic salmon > 1.5 kg. 
The basal diet (D1) contained 15 % fish meal (Karmsund fishmeal, AS, Norway), and the 
main plant ingredients was pea protein concentrate (Agrimarin Nutrition, Stavanger, 
Norway), SPC (Imcopa, Hertogenbosch, The Netherland) and wheat gluten (Amygluten 180, 
Syral Belgium N.V., Aalst, Belgium), Table 1. Betafin was added as choline source and 
soybean based lecithin (Agrosom, Mölln, Germany) as phospholipid source due to low fish 
meal inclusion. Yttrium oxide was added to the feed as an inert marker at a level of 0.2 g kg
-1
. 
The experimental diets were all supplemented with synthetically produced free Ax in 
Carophyll Pink (CP 10 % (80 % All-E, 5 % 9-Z, 15 % 13-Z), DSM Nutritional Products, 
France SAS) at 55 mg kg
-1
. The experimental diets were balanced to meet the requirements of 
essential amino acids (Lys, Thr), NRC (2011). All diets were extruded in a Wenger TX-52 co-
rotating twin-screw extruder with die size 4.5 mm in diameter. The diets were stored frozen at 
-20 °C during the trial, in order to avoid loss of Ax.  
2.3 Experimental fish trial 
The experiment was carried out in 12 experimental net-pens at Nofima’s aquaculture research 
station at Averøy, Norway (63° 03′N, 7° 35′E). At the start of the experiment, the salmon (1.7 
kg ± 0.01 kg) were randomly distributed to twelve 5 m x 5 m x 5 m (125 m
3
) cages, each 
holding 55 fish. The fish were fed one of four experimental diets, in triplicate net-pens for a 


















7 m x 7 m x 5 m (245 m
3
) cage and fed a pigment-free diet (similar to D1) with ~2.4 mg Ax 
kg
-1
. The fish was fed commercial Skretting feeds during transfer and prior to the 
acclimatization at Averøy. The salmon were from the Salmobreed strain and was delivered as 
0
+
 smolts from Nofima’s aquaculture research station, Sunndalsøra, Norway.  
The fish were fed three 30 min meals daily by feeding automates (Betten Maskinstasjon AS, 
Vagland, Norway). Unconsumed feed were collected in a plastic tarpaulin connected under 
the net-pen, pumped back to the surface through a plastic pipe using pressurised air, collected 
in a fine meshed sieve and the pellet weights recorded. Recovery tests were done with each 
diet in empty net-pens after finishing the trial, to adjust for nutrient loss in the wet feed-waste 
(Helland et al., 1996). Pumping of waste feed from the bottom cone in each cage started 4 min 
after termination of the meal and collection lasted for 4 min. Based on the feed intake from 
the previous 2–3 days, and unconsumed feed collected, the feeding rations were adjusted to 
about 10 % in excess of fish appetite. The fish were exposed to ambient temperature and light 
regimes during the trial. The water temperature was measured daily and decreased throughout 
the trial. Average temperatures measured at 2 week intervals were 9.1, 8.1, 7.4, 5.8, 4.7 and 
4.6 °C, respectively in the trial period from October to January, and average temperature in 
the total feeding period was 6.8 ± 1.7 °C. The ambient temperature decreased below 5 °C in 
the last 4 weeks of the trial and this had a negative influence on feed intake in fish.   
At the start of the experiment, the salmon were dip-netted from the 7 x 7 cages, anaesthetized 
in Finquel (Western Chemical Inc., Scottsdale, USA, 0.35 gL
-1
) and the individual weights 
(nearest 10 g) and fork lengths (nearest 0.5 cm) were measured. Fish with weights in the 


















were collected for analyses of flesh pigmentation and lipid content at start of the trial. Two 
samples of 10 fish were sampled prior to the Ax depletion period.    
At the end of the trial, continuously fed fish from each cage was anaesthetised in Finquel 
(Western Chemical Inc., Scottsdale, USA, 0.35 g L
-1
) in an outdoor tank supplied with 
running seawater. Pooled samples of approximately 30 - 40 g of faeces (w/w) were collected 
by manual stripping (20-30 fish), and the samples immediately frozen at -20°C for analyses of 
protein, lipid and Ax digestibility. Ten fish from each cage were transported to a nearby 
processing room and blood withdrawn from Vena caudalis (5 ml heparinized syringes, 5000 
IE heparin). Individual blood samples were kept refrigerated on ice (4 ° C) and centrifuged at 
4000 rpm/6 min. The plasma samples were collected and stored in dry ice (-80°C) before 
transport and storage at -30 °C for analyses of plasma Ax at the Nofima laboratory, 
Sunndalsøra. Following blood sampling, the fish was killed with a blow to the head, gutted, 
the sex registered (mature fish was not included) and fish measured for weight, fork length, 
gutted weight and liver weight, and for calculation of condition factor (C-factor), 
hepatosomatic index (HSI) and dress out percentage (% DOP). Both sides of the fillet was 
collected, the left half side was used for visual (Salmofan), colorimetric (Photobox) and 
chemical (Ax) measurements, and for calculation of muscle Ax retention (ret) according to 
the following formulas (BW2 = final body weight, BW1 = initial body weight; Ax2 = final Ax 
concentration, Ax1 = initial Ax concentration): 1) mg Ax ret = 0.61 x  [(BW2 · Ax2) – (BW1 · 
Ax1)]; 2) % of Ax consumed = mg Ax ret x 100/mg Ax consumed; 3) mg Ax kg
-1
 weight gain 
= mg Ax ret/(BW2-BW1); 4) % of dietary Ax absorbed = % Ax consumed x 100 / ADCAx. 
Muscle Ax retention was calculated as follows: Whole body Ax x 0.61 according to Wathne 
et al. (1998). The right half side of fillet and liver (n = 10) were immediately frozen at -30°C. 


















lipid peroxidation (TBARS). Small liver and muscle samples collected for gene expression 
analysis, TBARS and antioxidant enzyme essays (superoxide dismutase (SOD), gluthation 
peroxidase (GPX) and catalase) were snap frozen in liquid nitrogen (N) and stored at -80 °C, 
n=5 per cage. Small samples of muscle were also snap frozen in liquid N for FT-IR 
spectroscopy, n=4 per cage. Pooled samples of vertebrae (n=5 per cage) were collected 
according to the procedure described in Albrektsen et al. (2017) for analyses of bone ash and 
mineral contents.  
Growth and feed conversion ratio were determined according to the following formulas (BW2 
= final body weight, BW1 = initial body weight):  Specific growth rate, SGR = (ln BW2 - ln 




) * 1000 / 
(temp.(°C) * feeding days) according to Cho (1992). Feed conversion ratio (FCR) = g dry 
feed eaten / g live weight gain. 
During the last 3 weeks of the trial, mortality increased in all cages apparently without any 
signs of wounds or infections. The fish were diagnosed with cardiomyopathy syndrome 
(CMS), an infection induced by a virus, piscine myocarditis, that apparently have no impacts 
on feed intake or growth, however it cause severe damage to the heart and produce high 
mortality (Haugland et al., 2011). Potential impacts of piscine m. on pigmentation, antioxidant 
enzymes and TBARS in CMS infected fish is difficult to predict. The heart from each 
individual sampled fish (n=10) was therefore collected for gene expression analyses of piscine 
m. virus (PMCV). Individuals with relative gene expression level of PMCV > 20 were 
discarded, while individuals with relative PMCV > 10 were not used for the molecular 


















2.4 Chemical analyses 
All chemical analyses were carried out in duplicate by accredited laboratories at Nofima. In 
feed ingredients, diets, faeces and fish tissues, crude protein (N x 6.25) was determined by the 
Kjeldahl method (ISO 5983-1997), moisture gravimetrically after drying for 4.5 hours at 103 
± 1 °C (ISO 6496-1999), and ash after combustion for 16 hour at 550°C ± 20 °C (ISO 5984-
2002). Lipid contents in feed and faeces were determined by respectively acid hydrolysis 
(«EU-lipid»), (Commission Directive 98/64/EC, Part B) and by Folch extraction with acid 
hydrolysis (SSF-report: A-102, 1978). The lipid contents in liver and muscle were determined 
by Folch. Total and free Ax in the experimental feeds during storage were analyzed according 
to a HPLC (high performance liquid chromatography) method developed by Hoffman La. 
Roche (1994) following ethanol and dichloride methane extraction of Ax from the 
experimental diets. Carophyll Pink in the experimental diets was enzymatically treated in hot 
water prior to the extraction procedure. The pooled homogenized muscle, liver and faeces 
samples were thawed, and carotenoids were extracted from samples of accurately weighed 
minced salmon tissue using a 1:1:3 mixture of distilled water, methanol (containing 500 mg 
l
− 1
 BHT), and chloroform according to Bjerkeng et al. (1997). Blood plasma samples (1.0 ml) 
was added methanol (1.0 ml; containing 500 ppm butylated hydroxytoluene, BHT), mixed 
(Whirlmixer, Fisons, England), added chloroform (3 ml) before remixed, centrifuged (ca. 
1700×g, 10 min) and analyzed according to Wathne et al. (1998). External standard methods 
were used to quantify individual carotenoids and the geometrical E/Z isomer composition of 
Ax in the various samples. Two different isocratic HPLC systems were used to determine 
carotenoid concentrations in muscle, liver, blood and faeces samples, respectively (Bjerkeng 
et al., 1997). Yttrium was determined in feed and faeces by inductively coupled plasma 


















by HPLC and fluorescence detection after saponification and extraction according to Lie et al. 
(1994). Total P in ingredients and experimental diets were determined spectrophotometrically 
(430nm) after ashing and acid digestion in 6 M HCL (ISO 6491-1998). Soluble P was also 
determined spectrophotometrically according to the same method, however, following 
incubation of duplicate samples (0.8 g) in 80 mL, 1 N NaOH for 16 h according to the method 
described in Ruban et al. (2001) and Hua et al. (2005), and later modified and validated by 
Hovde (2013).   
2.5 Visual colour analysis  
The visual colour of the fillets were measured using the Roche SalmoFan
TM
 score (Hoffman 
La-Roche, Basel, Switzerland) and by digital image analysis using a standardized photo box, 
a digital camera and prediction equations for Ax (mg kg
-1
), Salmofan score and fat (%) 
(Folkestad et al., 2008). The left fillet side was placed in a Salmon Colour Box with 
standardized light conditions and SalmoFan readings were performed immediately after 
slaughter in 3 positions (upper dorsal, NQC and tail) in the upper region of the fillet by two 
individual judges. The fillets were then photographed by a digital camera (Dolphin F145C, 
Allied Vision Technologies, Stadtroda, Germany) in a light proof aluminium box (800 mm × 
830 mm × 955 mm) with standardized illumination provided by four fluorescent bulbs 
(OSRAM Lumilux 55 W, OSRAM, Augsburg, Germany) placed along each of the walls in 
the upper part of the box, as described (Folkestad et al., 2008). A calibration card, QPcard 
101, (QPcard AB, Gothenburg, Sweden) was used for calibration of lightness and white 



















After the feeding period of 79 days, fish from each tank were anaesthetized in Finquel 
(Western Chemical Inc., Scottsdale, USA, 0.35 g L
-1
), manually stripped for feces (20 - 30 g 
wet material) and immediately frozen at -30°C. Apparent digestibility coefficients (ADC) of 
lipid, protein and Ax were determined. Yttrium, lipid, Kjeldahl-N and Ax were analysed in 
the four experimental diets and in pooled samples of faeces from each replicate net-pen (n=3 
per dietary treatment). Samples of frozen faeces were lyophilized (final plate temperature 24 
°C) and homogenized prior to chemical analyses. Apparent digestibility coefficient (ADC) of 







Where d is diet, f is faeces, Y is yttrium concentration and CX nutrient concentration.  
2.7 Real time qPCR 
Total RNA was isolated using RNeasy® Mini Kit and RNase-Free Dnase set (Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol. cDNA was made from 500 ng RNA in a 
20 μL reaction volume by using AffinityScript QPCR cDNA Synthesis Kit (Agilent 
Technologies, CA, USA). The cDNA synthesis was run under following conditions: 25 °C for 
5 minutes, 42 °C for 45 minutes, and 95 °C for 5 minutes. The reaction mix for qPCR 
consisted of 4 μl diluted (1:10) cDNA, 1 μl forward and reverse primer (final concentration of 
0.5 μM), Table 2, and 5 μl SYBR Green-I Master (Roche Applied Science, Germany). The 
qPCR reaction was run on a LightCycler480 (Roche Diagnostics Gmbh, Germany) under 
the following conditions: 95 °C for 5 minutes, 45 cycles at 95 °C for 15 seconds and 60 °C for 


















product. The gene expression level was calculated according to the Ct method (Pfaffl, 
2004), using nduf (in vitro trial) or eif3 (in vivo trial) as reference genes and by calculation of 
gene expression in the various treatments relative to the control treatment. The treatment 
responses was tested for significant differences at a significance level of P < 0.05.  
2.8 Measurements of antioxidant enzymes 
SOD enzyme activity was measured using Superoxide Dismutase Assay Kit (Cayman 
Chemicals, Ann Arbor, MI, USA) according to the manufacturer’s protocol. The enzyme 
reaction was measured at 450 nm in a Spectrostar Nano plate reader (BMG LABTECH 
GmbH, Ortenberg). Enzyme activity of GPX was measured using a commercial kit (Cayman 
Chemicals, Ann Arbor, MI, USA), following the manufacturers’ protocol. The reaction was 
read at 340 nm in a Spectrostar Nano plate reader from BMG LABTECH GmbH (Ortenberg). 
Catalase enzyme activity was measured according to a method described in Baudhuin et al. 
(1964). Hydrogen peroxide produced in the peroxisomes, is decomposed by catalase into 
oxygen and water. The reaction is stopped by addition of a saturated solution (0.45 %) of 
titanium oxysulfate in 2 M sulfuric acid. Titanium oxysulfate reacts with hydrogen peroxide 
and produces a yellow solution of peroxy titanium sulfate. This was measured 
spectrophotometrically at 405 nm in a Spectrostar Nano microplate reader from BMG labtech 
GmbH (Ortenberg). 
2.9 TBARS 
Thiobarbituric acid reactive Substances (TBARS) was determined by using a commercial 
colorimetric assay kit (Cayman Chemical, Ann Arbor, MI, USA) following the 
manufacturers’ protocol. Tissue samples for TBARS analysis were prepared by homogenizing 


















and then twice in PBS. Finally, the cells were harvested in 1 mL PBS and centrifuged for 2 
minutes at 107 x g and 4 °C. Pelleted cells were resuspended in 250 µl PBS and sonicated 
three times for 5 seconds on ice. The absorbance at 532 nm was measured in a Spectrostar 
Nano microplate reader from BMG LabTech GmbH (Ortenberg, Germany). 
2.10 Fourier transform infrared spectroscopy (FT-IR) 
Muscle tissue cryo sections from fish fed different diets was analysed by FT-IR. An optical IR 
spotlight 400 microscope (Perkin Elmer) coupled to a Spectrum 400 FT-IR spectrometer 
(Perkin Elmer, UK) was used to measure the tissue sections. Spectra were collected from 
different connective tissue regions in the frequency range 4000 to 750 cm
-1
 using a mercury 
cadmium telluride (MCT) detector, and with spectral resolution of 8 cm
-1
, 64 scans per pixel 
and spectral interval of 4 cm
-1
. A background spectrum of the ZnSe substrate was recorded 
before each sample measurement in order to account for variation in water vapour and CO2 
level. Second derivative of the spectra were taken applying the Savitzky-Golay algorithm 
before further preprocessing by extended multiplicative signal corrections (EMSC) in The 
Unscrambler version 9.2 (Camo Process AS, Oslo, Norway) to remove multiplicative and 
wavenumber-independent and -dependent baselines. To analyze the main variation in FT-IR 
absorbance bands of connective tissue between fish fed different diets, data analysis of 
connective tissue parameters was performed according to Camacho et al. (2001) and principal 
component analysis (PCA) without further standardization of variables. 
2.11 In vitro hepatocyte study 
To understand the mechanisms of FBH stimulated uptake and transport of Ax at the cellular 
level, a separate in vitro study with hepatocytes was conducted. Atlantic salmon (ca. 600 g) 


















commercial diet prior to isolation of hepatocytes. The hepatocytes were isolated according to 
the method of Dannevig and Berg (1985). After isolation, the cells were filtrated through a 
100 μM nylon filter. The cells were washed three times in L-15 medium (Sigma-Aldrich, St. 
Louis, USA) and centrifuged for 2 minutes at 100g between each wash. Finally, the cells were 
added Glutamax growth media containing 10 % fetal calf serum, 1 % bicarbonate, 5mM 
Hepes and 1 % PenStrep (Sigma-Aldrich, St. Louis, USA). Approximately 4 x 10
7
 cells were 
seeded in 9.6 cm
2
 wells coated with laminin (Merck Millipore, Darmstadt, Germany). Cells 
were cultured at 13°C overnight and then added the experimental growth media. The 
experimental growth media consisted of 2 % foetal calf serum, 1 % bicarbonate, 5mM Hepes 
and 1 % PenStrep, and either FBH, Ax or a combination of FBH + Ax. The concentration of 
FBH was adjusted to provide 600 µg/mL P to the cells. Ax (Hoffman LaRoche) was 
complexed with bovine serum albumin (BSA, Sigma Aldrich) and added to the cell culture 
medium at a concentration of 1.5 mg L
-1
. Cells were cultured in experimental growth media 
for 48 hours before harvesting of the cells to the different analysis; including genetic markers 
for uptake and transport of Ax (Harrison et al., 2012), for stress and inflammation, and for 
activity of enzymes involved in the antioxidant defense of fish (Østbye et al., 2011; 
Todorcevic et al., 2009).  
2.12 Stability of total astaxanthin during feed production and storage 
Stability of free Ax during incremental heating of the mixed feed ingredients prior to 
extrusion (maximum 88°C, 3 min), extrusion (approximately 120°C, 1 min) of the feed blend, 
drying of the extruded pellets in a hot air drought (maximum 70°C, 45 min) and during 
coating with heated oils (45°C, < 2 min) were calculated from the analysed free Ax values, 
only corrected for variable moisture during feed production. The contents of free Ax in the 


















Batches of experimental diets were also stored in cabinets equipped with heating elements to 
keep the temperature under controlled conditions at 15°C and 25°C during storage. Small 
samples (100 g) of diets were collected at start and after 4, 8 and 12 weeks of storage (n=2 per 
feed). All samples were homogenized and analysed within one day for accurate measurements 
of Ax.  
2.13 Statistical analyses  
Biological and analytical data were subjected to regression analyses and one-way analysis of 
variance (ANOVA) using Statistica software (Ver 7.1, StatSoft, Tulsa, OK, USA) and SAS 
9.4 software (SAS Institute Inc., Cary, NC, 2002-2012). Significant differences in body 
weight, growth parameters and feed intake were tested by using Tukey HSD Test with 
probability P < 0.05. Significant differences between diets were otherwise tested by using 
Duncan’s Multiple range Test with the probability of a P value < 0.05 or P < 0.01 considered 
as significant (Zar, 1999). Pearson correlation and Spearman’s rank correlation analysis was 



















3.1 Composition of FBH ingredient and experimental feeds 
Total protein content in the hydrolysed fish bone ingredient was 10.8 % (corrected for total 
volatile nitrogen (TVN=2.7 %)), total sum amino acids 6.2 g100g
-1
 protein, lipid 1.1 %, ash 
61.5 %, salt 1.7 % and dry matter 97.9 %. The collagen protein characteristic amino acids 
Glutamine (Glut), Glycin (Gly), Arginin (Arg), Alanin (Ala) and Prolin (Pro) accounted for 
60 % of total protein (Fig. 1). The FBH mineral contents reflected the mineral contents in blue 
whiting FBH in Albrektsen et al. (2017) and contained 27.1 % potassium (K). The calcium 
(Ca) level in FBH was low (0.4 %), as most of Ca was precipitated as CaSO4 during 
processing.  
The ingredient composition and the chemical contents of the diets are shown in Table 1. The 
diets were iso-caloric and the energy content average 26.2 ± 0.2 MJ kg
-1
 on dry matter (DM) 
basis. The diets contained average 392 ± 2 g kg
-1
 protein and 351 ± 6 g kg
-1
 lipid, 
respectively. Besides from slightly higher Arg and Gly levels (13-14 %) in diet D3 due to 
inclusion of FBH, the non-protein N compounds creatinine, taurine and anserine were about 
20 – 50 % higher as compared to the control diet (D1), however, accounted for only 0.25 % of 
diet D3.  
Dietary Ax was average 59.2 ± 1.9 mg kg
-1
 (DM) for all diets following pellet extrusion, 
while the dietary level of soluble P was average 8.7 ± 0.4 g kg
-1 
(DM), Table 1. The low basal 
level of free Ax in all diets (2.4 ± 0.2 mg kg
-1
) originated from Ax in the fish oil, and was also 
present in the “pigment free” diet (formulated as D1) used for depletion of muscle Ax during 


















3.2 Stability of Ax during feed extrusion and storage 
During extrusion, no diet dependent differences in stability of total Ax were found. Dietary 
total free Ax was average 55.5 ± 1.3 mg/kg following extrusion, and the processing loss was 
very low, < 5 % and showed no diet dependent differences. Therefore, these data are not 
presented. During storage of the feeds, dietary total free Ax recovered after 12 weeks at 15 °C 
was similar, i.e. 87, 88, 82 and 89 % for D1, D2, D3 and D4, respectively, Fig. 1A. At 25 °C, 
dietary Ax recovered after 12 weeks of storage was 80, 80, 62 and 84 % for D1, D2, D3 and 
D4, respectively, indicating lower Ax stability in D3, Fig. 1B. The stability of dietary all-E 
and Z-isomers closely resembled free Ax stability in all diets, and are therefore not presented. 
3.3 Growth and feed utilization 
During the feeding trial the fish showed a high growth rate relative to the low water 
temperature, with an average specific growth rate (SGR) of 0.52 ± 0.03 % and thermal growth 
coefficient (TGC) of 3.19 ± 0.22 for all diets, Table 3. The fish increased the body weights 
from 1.7 to 2.5 kg during the feeding trial. The final weights and growth measurements was 
not significantly different between experimental diets, P > 0.05, Table 3. However, fish fed 
D3 and D4 both improved SGR by about 4% and showed lower in between net-pen variation 
as compared to D1 and D2. In fish fed the K2SO4 supplemented diet (D4), the feed intake 
(%/BW/d) was significantly increased by 17 %, P < 0.05. The increased feed intake was not 
reflected in increased growth, thereby increasing FCR by about 12 % (P < 0.05). No obvious 
explanation for the feed intake stimulation in fish fed D4 has been found.  
3.4 Mortality 
Total mortality in the experiment ranged from 9 to 14 % (Table 3) and started to appear after 


















syndrome (CMS), a common virus infection in Norway (Haugland et al., 2011). The mortality 
showed no diet dependent differences (P > 0.05), but the mortality was lowest in fish fed D3.  
3.5 Nutrient digestibility, Ax retention and tissue Ax composition  
At the end of the trial, the feed intake was low in the fish reared at temperatures below 5 °C, 
and in some fish, the faeces content was low or absent. The digestibility measurements varied 
between tanks, and in D4, one sample regarded as an outlier was omitted from the data set. 
The apparent digestibility of protein, lipid and Ax was not significantly different between 
dietary groups (P > 0.05), Table 4. However, apparent Ax digestibility was increased about 18 
% in fish fed D3 (FBH, 4 %), Fig. 2, as compared to the control diet (D1), and a tendency 
towards lower levels of both Ax trans and Ax cis isomers in faeces was observed (P > 0.05). 
Plasma, liver and muscle Ax in fish fed D3 were non-significantly increased by 22, 30 and 7 
%, respectively, compared to fish fed D1 (P > 0.05), Fig. 2. Muscle Ax retention was 
significantly increased (P < 0.05) by 40, 35 and 35 %, respectively, when measured as mg Ax 
retained (P < 0.05), % of dietary Ax consumed (P < 0.05) and mg Ax kg
-1
 weight gain (P < 
0.05), Table 4. Muscle Ax retention in fish fed D3 was numerically higher than in fish fed D4, 
while significant different only when measured as % of Ax consumed (P < 0.05). Muscle Ax 
calculated as % of dietary Ax digested (≈ utilization of Ax absorbed), was weakly increased 
in fish fed D3 versus D1 (P > 0.05).  
Plasma and liver x correlated (R = 0.7, P < 0.05), while no such relation was found between 
plasma and muscle Ax (P > 0.05). Plasma and muscle trans Ax accounted for average 92.8 ± 
0.8% and 92.0 ± 0.3%, respectively, for all diets. In liver, the relative amount of trans Ax was 


















6 % of total carotenoids and was consistently lowest in fish fed FBH (D2 and D3). As no 
significant differences was found (P > 0.05), these data are not presented.  
3.6 Visual (Salmofan) and colorimetric (Photobox) flesh pigmentation  
Muscle pigmentation evaluated by Salmofan in the upper dorsal, NQC and tail region 
correlated significantly to muscle Ax concentration (r > 0.70, P < 0.05). Visual colour 
measured by Salmofan was average 28.2 ± 0.4 for all groups, and showed no diet dependent 
differences (P > 0.05). Pigmentation measured colorimetric (Photobox) was average 26.2 ± 
0.7, and reflected muscle Ax (R = 0.54) with 10 % higher muscle Ax in fish fed D3 as 
compared to D1 (ns).  
3.7 Oxidation, inflammation and antioxidant enzymes in salmon 
There were tendencies towards higher levels of TBARS in liver and muscle of salmon fed D3 
compared to the other dietary treatments, but these changes were not significant (P > 0.05), 
Table 5 and Table 6. However, salmon fed D3 (FBH 4.2 %) showed reduced activity of GPX 
in liver as compared to salmon fed the control diet (D1) and diet D2 (FBH 2.1 %), Table 6. 
There was no significant difference in SOD activity between salmon fed Diet 1-3, whereas 
fish fed D4 supplemented with K2SO4 showed lower SOD activity than fish fed D2 (FBH 2.1 
%), Table 6. There were no differences in catalase activity between the diets (P > 0.05), Table 
6.  
Gene expression analysis of liver showed small differences in markers for antioxidant defence 
mechanisms (gpx3 and nfe2) and inflammation (nfkb), Table 6. However, salmon fed D3 
(FBH 4.2 %) had significantly lower gene expression of gpx3 compared to salmon fed D2 


















Table 5. Gene expression for the muscle structural protein myosin was significantly down 
regulated in salmon fed D3 compared to D1 and D2 (P < 0.05). No significant differences 
were detected for the muscle regulatory genes (myog and myod1b). 
3.8 In vitro hepatocyte study  
The Ax uptake in the hepatic cells measured in vitro did not show any significant impact by 
addition of FBH (P > 0.05), but tended to be slightly decreased, Table 7. Salmon hepatocytes 
cultured in FBH and FBH + Ax showed reduced activity of GPX compared to the control (P < 
0.05). SOD activity was significantly increased in hepatocytes added FBH + Ax as compared 
to the control (P < 0.05), and SOD was also markedly increased by FBH alone, Table 7. 
Catalase activity was significantly reduced only by FBH alone (P < 0.05). Addition of Ax 
alone did not change GPX, SOD or catalase activity relative to the control. There was no 
effect of FBH on gene expression of an inflammatory marker (nfkb), but FBH and FBH + Ax 
significantly increased expression of some markers of the antioxidant defence mechanism 
(gpx3 and nfe2), and reduced mitochondrial and peroxisomal -oxidation (cpt1 and acox), 
Fig. 2A, B. FBH and FBH + Ax also reduced the gene expression level of the Ax receptors 
(cd36 and scarb1) and Ax transport proteins (abca1) significantly, Fig. 2C, 2D. 
3.9 Connective tissue of skeletal muscle analysed by FT-IR  
Skeletal muscle of fish fed the experimental diets D1 (control), D3 (FBH 4.2 %) and D4 
(K2SO4) were analysed for connective tissue components by FT-IR. A significant difference 
in the structural density of the connective tissue, calculated as GAG/amid 1 ratio was detected 
in fish fed D3 as compared to the control diet (D1), with a significant higher ratio of 


















relative to collagen. The collagen crosslinks ratio (maturation) revealed no significant diet 
dependent differences (P > 0.05).  
The main variation in FT-IR absorbance bands of single connective tissue components 
between fish fed different diets were analysed by principal component analysis (PCA). A 
tendency of 3 separate groups was observed by comparing the carbohydrate of 
proteoglycans/glycoproteins, collagen (amid III) and sulfation of proteoglycans/ glycoproteins 
region in a combined PCA plot (Fig. 3). Along the X-axis (PC-1), explaining 95 % of the 
variation, diet D3 appeared to group differently from D1 and D4, which may reflect the 
significant impact on GAG/Amid 1.  
3.10 Bone ash and mineral contents 
Vertebra ash, P and Ca showed no diet dependent differences (P > 0.05). Mean values for all 
diets were respectively; Ash: 16.6 ± 0.6 %; Ca: 54121 ± 3199 mg kg
-1
 and P: 29509 ±1299 
mg kg
-1




















The present study suggest that fish bone ingredients produced from blue whiting may improve 
the Ax utilization by increasing the intestinal Ax uptake and muscle Ax retention in Atlantic 
salmon. More extensive improvements in Ax utilization has previously been observed in 0
+
-
smolt fed acid hydrolysed fish bone compounds, with respectively 55, 29 and 37 % higher 
plasma, liver and whole body Ax levels (unpublished data). A high Ax deposition rate in the 
flesh may be a result of increased uptake from the intestine, decreased metabolic turnover of 
the digested Ax or increased Ax uptake in the tissues. All of these potential altered 
mechanisms were studied and the results used to understand the physiological impacts of the 
fish bone ingredients on Ax utilization. The results also showed that the hydrolysed fish bone 
compounds altered the connective tissue compounds in the muscle of Atlantic salmon. These 
results are also discussed, as they may be of relevance for flesh quality and texture in salmon. 
Absorptive processes in the gut constitute a major limitation for the effective absorption of 
carotenoids in salmonid fishes. The ADCAx vary considerably, but typically range from 20 to 
60 % (Bjerkeng et al., 1997; Bjerkeng and Berge 2000; Ytrestøyl et al., 2005, 2008). In the 
present study, the ADCAx was average 24 % in fish fed D1, D2 and D4, and 29 % in fish fed 
D3, all below the Ax digestibility of 40 % reported in Atlantic salmon reared at the same 
location and time of the year (Ytrestøyl at al., 2006, 2008). Ax digestibility is positively 
correlated to water temperature, and negatively to feed intake and diet concentration 
(Torrissen et al., 1995; Ytrestøyl et al., 2005, 2006; Rørvik et al., 2010). Despite low water 
temperature and consequent low ADCAx values in the present trial, the moderate increase in 
ADCAx in fish fed D3 was followed by moderate increased plasma and tissue Ax levels, and 
significant increased muscle Ax retention. All diets were stored frozen until used, hence no 


















towards improved Ax digestibility, occurred (Bjerkeng et al., 1997; Østerlie et al., 1999). The 
results suggests improved Ax utilization in large salmon, although the impact of FBH is less 
pronounced as compared to the previous observations in smolt. The FBH ingredient contains 
acid hydrolyzed amino acids characteristic of collagen, one of the most important protein in 
the connective tissues. In human nutrition, hydrolyzed collagen proteins appear to have a 
great potential as nutraceutical ingredients, among others by preserving of high quality of skin 
and bone (Bello and Oesser, 2006). Potential impacts of the acid hydrolysed fish bone 
compounds on the gut integrity and digestive functions in fish has to be further studied to 
understand the mechanism behind the tendency towards increased Ax digestibility as 
indicated in the present study. 
The Ax digestibility was measured once, whereas the retention efficiency in the flesh was 
measured during a period of two months and is therefore a more reliable measure of Ax 
bioavailability. The muscle retention of Ax is normally less than 10 % of the ingested amount 
in Atlantic salmon, but may vary from 2 to 15 % depending on fish size, diet concentration, 
growth rate and water temperature (Torrissen et al., 1989; Wathne et al., 1998; Bjerkeng et al., 
1999; Bjerkeng and Berge 2000). In the present study, the retention of Ax ranged from 4-6 % 
in the muscle, which is higher than the 3% observed at this location in large salmon (˂ 3 kg) 
in October and December (Ytrestøyl et al., 2008). The daily feed intake and presumably also 
growth was high in the initial 6-7 weeks of feeding, which may explain that the total growth 
and flesh Ax retention was fairly high despite the low temperature in the last weeks of 
feeding.  In the present study, 21.7 % of the digested Ax was retained in the flesh of fish fed 
D3 (FBH 4.2 %) which is more than twice as high compared to that reported by Ytrestøyl et 
al. (2008); who found that 9.5 % of digested Ax was retained in the flesh at a dietary Ax 
concentration of 50 mg kg
-1


















more of the absorbed Ax was deposited in the muscle in fish fed D3 compared to the control 
diet (D1).  
The plasma concentration of carotenoids is considered to be a good indicator of 
bioavailability of carotenoids in salmonid fishes (Kiessling et al., 1995, 2003; Storebakken 
and Goswami 1996; Ytrestøyl and Bjerkeng 2007). In the present study, plasma total Ax 
concentration was increased from 1.4 mg kg
-1
 in the control diet (D1) to 1.7 mg kg
-1
 in fish 
fed D3 (FBH 4.2 %), and a similar increase in liver total Ax from 1.3 to 1.7 mgkg
-1
 was also 
observed. At the same time, muscle Ax increased moderately from 4.6 to 5 mg kg
-1
. Despite 
non-significant increases in tissue Ax concentrations, muscle Ax retention was significantly 
increased by 35 - 40 % in fish fed D3. The present results suggests increased Ax utilization in 
response to dietary FBH despite the fact that the results are statistically weaker than 
previously observed in 0
+
-smolt. 
About 60 to 80% of the absorbed Ax is metabolically transformed into other compounds. Idox 
is the first reductive product of Ax, and accumulates in plasma and tissues of Atlantic salmon 
(Schiedt et al., 1988, 1989) and Arctic charr (Aas et al., 1997; Bjerkeng et al., 2000). It is 
detected in the blood of Atlantic salmon only 6 hours after force-feeding a meal containing 
14C-Ax (Aas et al., 1999), and is an indication of the metabolism at the time of sampling. In 
this study, slightly less Ax seem to be metabolized into Idox in the tissues of fish fed FBH. 
The small reduction in formation of Idox is not likely to explain 35 - 40 % increase in Ax 
retention as observed in fish fed D3. However, a major fraction of the ingested Ax may be 
metabolized into other colorless compounds, and the amount of Idox deposited in muscle and 


















of FBH on Ax metabolism cannot be ruled out on the basis of the results from the present 
study.  
A selective accumulation of all-E-Ax takes place in plasma and muscle whereas the Ax Z-
isomers accumulates in intestine and liver of rainbow trout (Bjerkeng et al., 1997; Østerlie et 
al., 1999) and Atlantic salmon (Bjerkeng and Berge, 2000). This was also the case in the 
present study, cis-isomers constituted 38-42 % of the Ax in liver and less than 10 % in muscle 
and plasma, irrespective of the diets. The FBH ingredient apparently did not alter the Ax 
isomers in any of the measured tissues.  
Several receptors and transport proteins such as scarb1, sd36, abca1 and rbp1/2 are involved 
in carotenoid/retinol uptake and transport (reviewed by Harrison et al., 2012). Mechanisms 
for Ax uptake and transport are still not known, but these receptors and transporters may be 
potential genetic markers. In the in vitro study, no positive effect of FBH alone or FBH + Ax 
on genes anticipated to be involved in tissue Ax uptake and transport (cd36, scarb1, rbp1/2 
and abca1) could be detected. Instead there was a significant down-regulation of gene 
expression for the receptors cd36 and scarb1, as well as for the transport protein abca1 with 
FBH alone, and for scarb1 and abca1 in FBH + Ax. Gene expression in Ax alone was not 
significantly different from the Control. This may indicate that Ax do not regulate expression 
of these genes or that these proteins are not essential for Ax uptake and transport. Although 
not significant, a tendency towards reduced uptake of Ax in the hepatic cells incubated with 
FBH was detected.  
Antioxidants systems, like the enzymes catalase, GPX and SOD, are essential in all organisms 
in order to prevent reactivate oxygen species from interfering with biological structures 


















intracellular antioxidant GPX was significantly reduced in hepatocytes cultivated in a medium 
supplemented with FBH alone and with FBH + Ax. These results mirrored what was found in 
the in vivo trial. Salmon fed D3 (FBH 4.2 %) showed reduced liver GPX activity and 
increased TBARS as compared to salmon fed the control diet (D1) and D2 (FBH 2.1 %), 
indicating oxidative stress despite no negative effect on growth. The results may suggest a 
dose dependent response to increased dietary FBH ingredient, confirming previous results on 
activity of this antioxidant enzyme in vitro due to the presence of high sulfate level (Østbye et 
al., 2017b). The tendency towards reduced hepatic uptake of Ax in the cell culture trial may 
be explained by reduced intracellular antioxidant capacity, i.e. lower GPX activity, which 
may lead to increased usage of Ax as antioxidant and consequently lower hepatic Ax uptake.  
Despite the indications of oxidative stress in liver, the hepatic Ax concentration in salmon fed 
D3 (FBH 4.2 %) was elevated by 22 % as compared to D1. This suggests that the modulatory 
role of the FBH ingredient may be explained by improved digestibility of Ax, leading to 
higher circulating Ax and increased tissue Ax deposition. In smolt, plasma and liver Ax were 
significantly increased by 55 and 29 %, respectively, in response to FBH (un-published data). 
Different fish sizes and in particular the low temperature at the time of sampling in the present 
study, may explain such differences.  
The in vitro study showed that FBH alone and FBH + Ax reduced gene expression of cpt1 
and acox, involved in the mitochondrial and peroxisomal β-oxidation. This may indicate that 
the fish bone ingredients reduce fatty acid oxidation, although this has to be further 
confirmed. The oxidative stress induced by the FBH ingredient may also explain the result. 
Among other, it has been reported that increased oxidative stress may damage the 


















Østbye et al., 2011). In the storage trial, dietary Ax in D3 appeared to be less stable at high 
temperature (25 °C), as compared to the other diets. This may be explained by increased Ax 
oxidation or destabilization of Carophyll Pink. In salmon fed FBH ingredients, no negative 
impacts on growth has been observed in juvenile fish from 15 g size (Ytteborg et al., 2016) or 
in 0
+
-smolt (Albrektsen et al., 2017). The method for extraction of the nutrients in the fish 
bones has however been changed, mainly by reducing the concentration of sulfuric acid, 
inevitably also reducing the need to adjust pH, as previously discussed (Ytteborg et al., 2016; 
Albrektsen et al., 2017). By using significantly less chemicals, the minerals can still be 
efficiently extracted and it has been shown that the FBH ingredient no longer affects hepatic 
GPX activity in vitro in a negative way (unpublished data).  
In addition to improving the muscle Ax retention, the D3 (FBH 4.2 %) diet affected 
connective tissue compounds in the muscle with regards to proteoglycans and their 
glycosaminoglycans (GAGs). The GAGs interact with a number of different factors, such as 
growth factors, cytokines, enzymes and lipids, and the biological roles of proteoglycans are 
diverse and fine-tuned by the sulfate pattern of the GAGs (Campo et al., 2004; Kreuger et al., 
2006; Lindahl, U. and Li, J.P., 2009; Rønning et al., 2013). The expression of different GAGs 
varies and impact the different stages in the myogenesis (Melo et al., 1996; Brandan et al., 
2008). In this study, mRNA expression of the muscle structural protein myosin was down-
regulated in fish fed D3 (FBH 4.2 %), as compared to the control diet (D1). Myosin is one of 
the main proteins in mature myofibers, important for muscle contraction. Down-regulation of 
myosin may indicate a change in the regulation of this signaling pathway of myogenesis, 
however, more experimental work is required to confirm this. The potential change in the 
signaling pathway of myosin may be associated with the changed amount of GAGs, its 


















D3 (FBH 4.2 %). Addition of K2SO4 in D4 did not have any impact on connective tissue 
composition, suggesting that dietary sulfate is not responsible for this physiological response. 
The effect of the FBH ingredient on the connective tissue compounds in the skeletal muscle 
may result from soluble compounds other than the minerals. Among other, FBH contains high 
levels  of amino acids (Hyp, Pro, Gly, Ala, Glut) characteristic of bone collagens (Toppe et 
al., 2007), of which some has been reported to improve growth or to affect muscle quality in 
fish (Aksnes et al, 2008; Albrektsen et al., 2010; Larsson et al., 2014; Østby et al., 2017). 
Some of the non-essential amino acids may become conditionally essential or physiologically 
advantageous in farmed fish exposed to extensive handling and stress (Li et al., 2009). 
However, the observed change in the connective tissue may also be explained by other 
soluble compounds released from the bones, such as non-protein N compounds, GAGs, 
specific microelements or combinations thereof. A changed composition of proteoglycans in 
skeletal muscle may be important for the textural properties of the flesh (Tingbo et al., 2005; 
Torgersen et al., 2013). GAGs are highly water binding due to its linear long unbranched 
polysaccharide chain structure with distinct sulfation pattern (Yanagishita, M., 1993). The 
increased GAG/amid ratio in our study may suggest higher water binding capacity of the 
fillet, and possibly improved fillet quality (Moreno et al., 2012). Flesh texture and color are 
two of the most important quality criteria in salmon. Confirmation of the physiological 
impacts of the acid extracted fish bone compounds on flesh quality and texture would be 
needed to claim such physiological properties of the fish bone ingredient.   
Conclusions  
In this study, a tendency towards improved Ax concentrations in plasma, liver and muscle of 


















increased Ax retention (35 - 40 %) in salmon muscle. The results suggests that the increased 
Ax utilization in the fish was explained by slightly improved Ax digestibility (ns), possibly 
combined with lower metabolic loss of Ax. The fish bone ingredient also altered the structural 
connective tissue compounds in muscle by stimulating the production of proteoglycans and 
their sulfated glycosaminoglycans (GAGs) significantly. Confirmation on how the fish bone 
compounds may affect connective tissues quality in the body is required to understand 
potential physiological implications. Refining of the process method used to hydrolyse the 
fish bones is in progress, aiming to maintain high processing yield of phosphorus (> 85 %) 
with minimal use of chemicals, and with no negative impacts on feed stability or any 
oxidation parameters in fish. This will contribute to make the fish bone ingredients attractive 
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Figure 1 Amino acid (g/100 g protein) composition of spray-dried fish bone hydrolysate (FBH) 
produced from blue whiting fish meal  
Figure 2 Apparent Ax digestibility (ADC Ax) and tissue Ax concentrations in fish fed D2 (2.1 % 
FBH), D3 (4.2 % FBH) and D4 (K2SO4) shown as the difference relative to fish fed D1 (control=100), 
P > 0.05. 
Figure 3 PCA plot of a region (1400-1185 cm-1) of connective tissue representing carbohydrate 
groups (from proteoglycans), amid III from collagen and sulphation of proteoglycans in fish fed D1 
























FBH 2.1 % 
D3 





     
Fish meal
a
 150 150 150 150 
FBH Blue whiting
b
  21 42  
SPC 190 190 190 190 
Wheat gluten 67 65 63 71 
Pea protein concentrate 100 100 100 100 
Lysine-HCl 8 8 8 8 
Thr 4 4 4 4 
Fish oil
c
 66 66 66 66 
Canola oil 236 236 236 237 
Soya lecithin 5 5 5 5 
Wheat 119 112 105 98 
Betafin 5 5 5 5 
Vitamin mix
d
 20 20 20 20 
Mineral mix
e
 5.2 5.2 5.2 5.2 
CaPO4 - MCP (T29/10) 2.4 1.2 0 2.4 
K2SO4 (18 %)     1.6 
Carophyll Pink, 10% 0.55 0.55 0.55 0.55 
Y2O3 0.2 0.2 0.2 0.2 
     
Diet composition     
Protein, g kg
-1 
 366 369 366 371 
Lipid, g kg
-1




















 64 64 70 49 
Ash, g kg
-1
 62 68 73 79 
Total P, % 11.9 11.5 10.8 12.1 





 24.8 24.6 24.2 24.8 
     
Dietary carotenoids, mg kg
-1
     
Total free Ax  56 55 57 54 
All-E Trans Ax 43 42 43 41 
9Z Cis Ax  2.3 2.2 2.4 2.4 




SILFAS, N-5892, Bergen, Norway. Protein: 708 gkg
-1
, Lipid: 110 gkg
-1
, Ash: 108 gkg
-
1




 FBH Blue whiting:  Protein: 89 gkg
-1
, Lipid: 16 gkg
-1
, Ash: 677 gkg
-1




 Norsalmoil, Norsildmel AL, N-5141 Fyllingsdalen, Norway 
d 
Vitamins added per kg feed: vitamin D3, 3000 I.E., 160 mg; vitamin E, 136 mg; thiamin, 20 mg; 
riboflavin, 30 mg; pyrodoxine-HCl, 25 mg; vitamin C, 200 mg; calcium pantothenate, 60 mg; biotin. 1 
mg; folic acid, 10 mg; niacin, 200 mg; vitamin B12, 0,05 mg; menadion bisulphite, 20 mg 
e 
Minerals added per kg feed: magnesium 500 mg; potassium 600 mg; zinc 120 mg; iron 60 mg; 


















Table 2. Primers for gene expression analysis. eukaryotic translation initiation factor 3 (eif3), 
nadh:ubiquinone oxidoreductase (nduf), glutathione peroxidase 3 (gpx3), catalase (cat), nuclear 
factor kappa b  (nfkb), nuclear factor, erythroid 2 (nfe2), myogenic differentiation 1b (myod1b), 
myogenin (myog), myosin (myl), acyl-coa oxidase (acox), carnitine palmitoyltransferase 1 (cpt1), 
scavenger receptor class b member 1 (scarb1), retinol binding protein 1 (rbp1 ), retinol binding 
protein 2 (rbp2), atp binding cassette subfamily a member 1 (abca1). 
Gene Genbank accession 
no. 
Forward (5'-3') Reverse (5'-3') 




















myog DQ294029 ATTGAGAGGCTGCAGGCACTTG GTGCGGTAGTGTAAGCCCTGTG
TT 
myl NM_001123716 CCATCAACTTCACCGTCTTCCTCAC CAGCCCACAGGTTCTTCATCTCC 
acox DQ364432 CCTTCATTGTACCTCTCCGCA CATTTCAACCTCATCAAAGCCAA 
cpt1 AM230810 GTACCAGCCCCGATGCCTTCAT TCTCTGTGCGACCCTCTCGGAA 
scarb1 DQ266043 AACTCAGTGAAGAGGCCAAACTTG TGCGGCGGTGATGATG 
cd36 AY606034 GGATGAACTCCCTGCATGTGA TGAGGCCAAAGTACTCGTCGA 























Table 3.  Daily specific growth rate (SGR, %), daily feed intake per fish and feed conversion rate 
(FCR) in Atlantic salmon fed experimental diets D1 (Control), D2 (FBH 2.1 %), D3 (FBH 4.2 %) and 
D4 (K2SO4) for a feeding period of 11 weeks. Mean values and STD (x) is given for each respective 




FBH 2.1 % 
D3 






 < 0.05 
Initial weight, g 1707 (7) 1693 (11) 1694 (13) 1698 (5) ns 
Final weight, g 2543 (93) 2489 (108) 2565 (55) 2560 (26) ns 
Weight gain, g 836 (89) 795 (99) 871 (44) 861 (29) ns 
SGR, % 0.51 (0.04) 0.49 (0.05) 0.53 (0.02) 0.53 (0.02) ns 
TGC 3.16 (0.29) 3.04 (0.32) 3.29 (0.13) 3.26 (0.10) ns 


















12.0 (1.5) 11.8 (1.5) 11.9 (0.3) 14.0 (0.6) ns 
Mortality, no. 
fish/diet 
21 23 15 22 ns 
Mortality, % 12.7 (4.8) 13.9 (1.0) 9.1 (3.6) 13.3 (7.3) ns 
1 
Significant differences within rows are shown with different superscript letters, P < 0.05, ns = not 
significant. 
2
 Feed intake (% of mean body weight (BW), per day) = % feed intake / days / ((BW2 + BW1)/2 * 
100) / fish no.  
3


















Table 4.  Digestibility of protein, lipid and astaxanthin (Ax), Ax carotenoids in faeces and total Ax 
utilization measured by muscle Ax retention in Atlantic salmon fed experimental diets D1 (Control), 
D2 (FBH 2.1 %), D3 (FBH 4.2 %) and D4 (K2SO4) for a feeding period of 11 weeks. Mean values and 




FBH 2.1 % 
D3 






 < 0.05 
Digestibility, %      
Protein 86.3 (1.0) 86.2 (0.3) 86.6 (0.8) 87.9 (1.2) ns 
Lipid 96.6 (0.7) 96.4 (0.5) 96.6 (0.4) 96.6 (0.6) ns 
Total Ax 24.4 (1.4) 23.9 (6.1) 28.7 (0.5) 24.4 (3.8) ns 
      
Faeces carotenoids, mgkg
-1
      
Total Ax 13.28 (1.54) 12.01 (1.44) 11.63 (0.71) 12.11 (1.60) ns 
All-E Trans Ax 10.18 (1.27) 9.05 (1.19) 8.64 (0.79) 9.32 (1.19) ns 
9Z Cis Ax  0.60 (0.10) 0.60 (0.08) 0.55 (0.07) 0.63 (0.11) ns 
13Z Cis Ax 2.27 (0.21) 2.07 (0.40) 2.03 (0.13) 1.98 (0.30) ns 
      
Total Ax utilization      



























Muscle Ax ret, % of Ax absorbed 19.0 (1.4) 16.5 (4.1) 21.7 (2.1) 18.2 (6.8) ns 
 1 
Significant differences is shown by different superscript letters (Duncan’s Post Hoc test, P < 0.05), 





































Table 5.  Chemical composition and gene expression in muscle of Atlantic salmon fed experimental 
diets D1 (Control), D2 (FBH 2.1 %), D3 (FBH 4.2 %) and D4 (K2SO4) for a feeding period of 11 




FBH 2.1 % 
D3 






 < 0.05 
      
Chemical composition, %     
Lipid 11.0 (1.0) 11.3 (0.6) 10.5 (0.7) 10.8 (0.4) ns 
Dry matter 31.7 (0.6) 31.9 (0.6) 31.6 80.5) 31.7 (0.3) ns 
Tocopherol, mgkg
-1
 21.0 (4.0 ) 19.5 (0.7) 18.7 (1.1) 19.2 (1.4) ns 
      
Gene expression relative to control     
myog 0.00 (0.89) -0.23 (0.94) -0.37 (1.30) 0.05 (0.89) ns 










      
Lipid peroxidation, g per g muscle     
TBARS 0.42 (0.28) 0.46 (0.35) 0.58 (0.26) 0.41 (0.19) ns 
 1 





















Table 6.  Chemical composition, gene expression and antioxidant defence enzymes (SOD, GPX and 
Catalase) in liver of Atlantic salmon fed experimental diets D1 (Control), D2 (FBH 2.1 %), D3 (FBH 
4.2 %) and D4 (K2SO4) for a feeding period of 11 weeks.  Mean values and STD (x) is given for each 




FBH 2.1 % 
D3 






 < 0.05 
      










Dry matter 27.6 (0.9) 26.5 (0.6) 25.6 (0.6) 26.4 (1.3) ns 
Tocopherol, mgkg
-1
 513 (134) 409 (10) 457 (51) 526 (118) ns 
      












nfkb 0.00 (0.50) 0.00 (0.45) -0.01 
(0.46) 
0.18 (0.58) ns 
nfe2 0.00 (0.43) 0.09 (0.43) 0.08 (0.48) 0.11 (0.56) ns 
      
Antioxidant defence enzymes     
























Catalase (U/g protein) 87.6 (21.8) 84.1 (22.2) 88.0 (19.9) 84.5 (17.2) ns 
      
Lipid peroxidation, g per g liver     
TBARS 6.07 (1.60) 5.66 (1.53) 6.96 (1.57) 6.08 (1.84) ns 
1 




















Table 7.  Astaxanthin (Ax) uptake, antioxidant defence enzymes (SOD, GPX, Catalase) and gene 







Ax FBH Blue 




 < 0.05 
      
Ax uptake 
μg Ax/μg protein  


























     
Antioxidant defence enzymes     
























0.79 (0.15) 0.90 (0.18) 0.70 (0.19) 0.94 (0.19) ns 
1 




















Table 8. GAG/Amid1 ratio and collagen crosslink in the skeletal muscle of Atlantic salmon fed the 
control diet (D1), and with diets added FBH 4.2 % (D3) or K2SO4 (D4). 
 
 
GAG/amid1 Std error Collagen 
crosslinks 
Std error 
D1: Control  0.34 0.06 3.12 0.62 
D3: FBH 4.2 %  0.46  * 0.07 3.82 0.57 
D4: K2SO4  0.35 0.05 4.27 0.60 
 






















Highlights of the manuscript 
 The process for extracting of nutrients in fish bones aid to increased utilization of 
available marine resources and novel applications of fish bone nutrients in aquaculture 
 Extracted fish bone compounds increase Ax digestibility and the circulating Ax levels 
(ns) and is followed by a significant increase in muscle Ax retention in Atlantic 
salmon 
 Extracted fish bone compounds change the connective tissue structures in the muscle 
by stimulating the production of proteoglycans and their sulfated glycosaminoglycans 
(GAGs) significantly 
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